What is PMCB's dilution risk score?

PMCB currently has a DilutionScore of 37/100, indicating medium dilution risk. DilutionWatch monitors PMCB SEC filings in real-time, scanning EDGAR every 60 seconds for shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals.

What SEC filings does DilutionWatch track for PMCB?

DilutionWatch tracks 25 SEC filing types for PMCB including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect PMCB shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For PMCB, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for PMCB tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for PMCB. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

PMCB Dilution Risk Score: 37/100 (MEDIUM)

📊 Score Breakdown

📋 Offering Ability

42

💰 Cash Runway

0

📊 Float Risk

30

⚠️ Warrant Exposure

90

🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️

Warning

High probability of dilution event

46%

📜 Warrant Exercise 60%

• Massive warrant overhang: 317% of shares outstanding

• Warrant risk score very high (90/100)

🔄 Reverse Split 55%

• 50-day avg $0.75 below $1 exchange minimum

🔔 Track PMCB — Get forecast alerts →

💹 Market Data

Market Cap$8.96M

Shares Outstanding10.74M

Float9.96M

Cash$20.54M

Debt$2.46M

Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 0.7% shares (2026Q1 vs prior)

32 institutional holders · 1.18M shares

#1 CITADEL ADVISORS LLC 519.7K shares

#2 GEODE CAPITAL MANAGEMENT, LLC 195.7K shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 102.9K shares

+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest326.1K

Days to Cover3.1

% of Float3.3%

FINRA data as of Jun 30, 2026

👤 Insider Buy/Sell Ratio

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 31, 2025

xbrl XBRL CONVERTIBLE Apr 30, 2024

Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for PMCB Shareholders

PharmaCyte Biotech, Inc. (PMCB) has a DilutionScore of 37/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch tracks 34.0M outstanding warrants for PMCB. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for PMCB in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for PMCB alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →